Wei Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wei Zheng has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Fei Kang
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China
14 shared publications - Hong-Yong Cui
Department of Cell Biology and National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi’an, China
14 shared publications - Jianhua Jiao
Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi’an, China
14 shared publications - Jing Zhang
Department of Pathology, Xijing Hospital The Fourth Military Medical University Xi'an PR China
14 shared publications - Jingliang Zhang
Department of Urology, Xijing Hospital, Air Force Medical University, Xi’an, Shaanxi, China
14 shared publications - Jixue Gao
Department of Urology, Affiliated Hospital of Yan’an University, Yan’an, China
14 shared publications
Latest Publications
- Open Access
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Table S8 The diagnostic accuracy of each biopsy in the combination of PSMA-TB and TRUS-GB
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Table S8 The diagnostic accuracy of each biopsy in the combination of PSMA-TB and TRUS-GB
- Open Access
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Representativeness of Study Participants
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Representativeness of Study Participants
- Open Access
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Distribution of Gleason scores according to the PI-RADS score.
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Distribution of Gleason scores according to the PI-RADS score.
- Open Access
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Figure S2. The distribution of SUVmax in different GS groups.
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Figure S2. The distribution of SUVmax in different GS groups.
- Open Access
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Table S6. Adverse events in the two groups subjected to prostate biopsy
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Table S6. Adverse events in the two groups subjected to prostate biopsy
- Open Access
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Table S2. Intraclass correlation coefficient of SUVmax measurement
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Table S2. Intraclass correlation coefficient of SUVmax measurement
- Open Access
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Table S5 The diagnostic performance of PSMA PET in combined and control group
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Table S5 The diagnostic performance of PSMA PET in combined and control group
- Open Access
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Table S4. Cancer detection rates by different biopsy methods
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Table S4. Cancer detection rates by different biopsy methods
- Open Access
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Table S1. Summary of the use of the PRIMARY scoring system for PCa detection by PSMA PET imaging
- 15 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET–Targeted Prostate Biopsy for Prostate Cancer Diagnosis
Table S1. Summary of the use of the PRIMARY scoring system for PCa detection by PSMA PET imaging